• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Neurology

Moderate to severe TBI is associated with elevated malignant brain tumor risk

byJayden BerdugoandSimon Pan
January 13, 2026
in Neurology, Oncology
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. In this retrospective cohort study, moderate to severe traumatic brain injury (TBI) was associated with an increased risk of malignant brain tumour development compared to mild TBI and no TBI.

2. Among the TBI group, a larger number of individuals had a mild TBI compared to a moderate to severe TBI.

Evidence Rating Level: 2 (Good) 

Study Rundown: Traumatic Brain Injury (TBI) has substantial prevalence among the general population and results in increased morbidity and mortality, though the mechanism is not fully understood. Brain tumors, though only confirmed to have an increased risk through ionizing radiation, have shown a potential link through TBI. Studies of military populations, a population with high TBI prevalence, have been limited by confounding factors. To shed some light on inconclusive population studies and to increase early detection of brain tumors, this study investigated whether a link between TBI and malignant brain tumors could be established. This retrospective cohort study used data from US adult civilians across a variety of trauma centres, using codes from the Centers for Disease Control and Prevention for TBI and malignant tumors. Among the exposure group, the majority of the participants had a mild TBI compared to a moderate to severe TBI. Furthermore, there was a larger number of participants in the moderate to severe TBI group who developed a malignant brain tumor compared to the mild TBI group and the control group. One limitation of the study was the inability to determine the specific types of malignant brain tumor associated with TBI. Despite this, the study found that a history of moderate to severe TBI was associated with a future risk of malignant brain tumor development. These results indicate that adults with a history of moderate to severe TBI may benefit from enhanced monitoring and follow-up to identify potential development of malignant brain tumors. To tackle the limitations of this study, future research into screening programs for TBI patients is recommended.

Click here to read the study in JAMA Network Open

Relevant Reading: Traumatic Brain Injury and Subsequent Risk of Brain Cancer in US Veterans of the Iraq and Afghanistan Wars

RELATED REPORTS

Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer

A chemical denervation intervention may be safe and effective for pain management in avascular necrosis of the hip

Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer

In-Depth [retrospective cohort study]: This retrospective cohort study was conducted on 151,358 individuals, split into two equal cohorts of 75,679 participants per group. Participants were included if they were aged 18 years or older and had two or more visits for TBI. Inclusion in the study was limited to a 1-year observation period and a history of prior radiation exposure. Among the Mass General Brigham (MGB) group, the median follow-up time was 7.2 (IQR, 4.1-10.1) years. In the TBI group, 80.3% of participants had mild TBI, and 19.7% had moderate to severe TBI. the incidence of malignant brain tumors was greater in individuals with moderate to severe TBI (87 [0.6%]) compared to those with mild TBI (222 [0.4%]) and the control group (314 [0.4%]) (P=.001). Among matched individuals, the moderate to severe TBI group had a higher rate of malignant brain tumors (87 [0.6%]) compared to the control group (64 [0.4%]) (P=.003). In the regression analysis, individuals with moderate to severe TBI had a significantly higher risk of developing malignant brain tumors (HR, 1.67; 95% CI, 1.31-2.12; P<.001) compared with those with mild TBI (HR, 0.99; 95% CI, 0.83-1.18), independent of confounding factors. Overall, these findings support the need for ongoing monitoring of individuals with moderate to severe TBI to help with earlier detection of malignant brain tumors. 

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: cancercancer detectionneurologyoncologytbi
Previous Post

2 Minute Medicine Rewind September 1, 2025

Next Post

Personalized risk messages may not increase colorectal cancer screening uptake

RelatedReports

Radiation plus hormone therapy may improve prostate cancer survival
Chronic Disease

Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer

July 22, 2026
MRI screening may improve osteonecrosis outcomes in children with leukemia
Chronic Disease

A chemical denervation intervention may be safe and effective for pain management in avascular necrosis of the hip

July 16, 2026
Rectal indomethacin dose escalation for prevention of pancreatitis after endoscopic retrograde cholangiopancreatography in high-risk patients
Chronic Disease

Chemotherapy exposure is independently associated with reduced pain severity in advanced pancreatic cancer

July 15, 2026
Epidural corticosteroid injections provide only short-term radiculopathy pain relief
Chronic Disease

Spinal instability may be the primary cause of pain in sacral metastases as opposed to neurologic compromise

July 14, 2026
Next Post
2 Minute Medicine Rewind October 21, 2019

Personalized risk messages may not increase colorectal cancer screening uptake

Low free sugar diet reduces hepatic steatosis in nonalcoholic fatty liver disease in adolescent males

Serum albumin-to-creatinine demonstrates an inverse and non-linear relationship with the risk of non-alcoholic fatty liver disease

An absence of cardiovascular risk factors is linked to over ten additional healthy years

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • All-oral chemotherapy regimen tolerable and efficacious for newly diagnosed acute myeloid leukemia
  • Enzalutamide (Xtandi) and abiraterone (Zytiga) may have similar effectiveness in metastatic castration-sensitive prostate cancer
  • Intermittent metformin (Glucophage) is non-inferior to continuous metformin for prediabetes in post-partum women with prior gestational diabetes mellitus
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.